← All Kyverna Therapeutics, INC filings

Kyverna Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
KYTX
Kyverna Therapeutics, INC
DEF: Kyverna Therapeutics Sets May 27 Annual Meeting
Kyverna Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for May 27, 2026, detailing proposals for director elections and auditor ratification.
NASDAQ
KYTX
Kyverna Therapeutics, INC
DEFA14A: Kyverna Therapeutics Sets Date for 2025 Annual Meeting, Outlines Voting Proposals
Kyverna Therapeutics announces its 2025 Annual Meeting of Stockholders, detailing proposals for director elections and auditor ratification.
NASDAQ
KYTX
Kyverna Therapeutics, INC
DEF: Kyverna Therapeutics Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
Kyverna Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on May 29, 2025, featuring proposals for director elections and auditor ratification.